XM, Amerika Birleşik Devletleri'nde ikamet edenlere hizmet sunmamaktadır.
I
I

IDEXX


Haberler

U.S. ANI Pharmaceuticals, Deere & Co, Zoetis

U.S. RESEARCH ROUNDUP-ANI Pharmaceuticals, Deere & Co, Zoetis Oct 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ANI Pharmaceuticals, Deere & Co and Zoetis, on Friday. HIGHLIGHTS * ANI Pharmaceuticals Inc ANIP.O : Piper Sandler initiates coverage with overweight rating * Deere & Co DE.N : JP Morgan raises target price to $420 from $360 * Northrop Grumman NOC.N : Citigroup raises target price to $587 from $521 * S
A
C
G
H
I
A
C
F
A
C
A
A
C
C
C
E

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Arm Holdings PLC ARM.OQ +9.2% NVIDIA Corp NVDA.OQ +7.3% Super Micro Computer Inc SMCI.OQ +6.8% Broadcom Inc AVGO.OQ +6.2% ASML Holding NV ASML.OQ +5.8% Bottom Performers Percent Change Palo Alto Networks Inc PANW.OQ -2.1% Take-Two Interactive Software Inc TTWO.OQ -1.8% O'Reilly Automotive Inc ORLY.OQ -1.8% IDEXX Laboratories Inc IDXX.OQ -1.7% Old Dominion Freight Line Inc ODFL.OQ
B
I
N
A
T
U
O

Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Arm Holdings PLC ARM.OQ +4.4% ASML Holding NV ASML.OQ +3.1% Super Micro Computer Inc SMCI.OQ +3.0% NVIDIA Corp NVDA.OQ +2.9% Starbucks Corp SBUX.OQ +2.1% Bottom Performers Percent Change Palo Alto Networks Inc PANW.OQ -3.3% IDEXX Laboratories Inc IDXX.OQ -3.0% Warner Bros Discovery Inc WBD.OQ -3.0% Old Dominion Freight Line Inc ODFL.OQ -2.9% Verisk Analytics Inc VRSK.OQ -2.6% The
I
N
S
V
A
U
O

U.S. Agenus, Guardant Health, Zoetis

U.S. RESEARCH ROUNDUP-Agenus, Guardant Health, Zoetis Aug 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agenus, Guardant Health and Zoetis, on Wednesday. HIGHLIGHTS * Agenus Inc AGEN.O : B. Riley cuts target price to $18 from $42 * Clorox CLX.N : Jefferies raises target price to $151 from $148 * Guardant Health Inc GH.O : Raymond James raises target price to $36 from $28 * Starbucks SBUX.O : Stifel raises to buy
A
C
D
E
I
E
A
A
C
E

U.S. STOCKS IDEXX, Amgen, Airbnb

BUZZ-U.S. STOCKS ON THE MOVE-IDEXX, Amgen, Airbnb Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
I
U
U
F
M
R
U
V
M

U.S. STOCKS Lumen Technologies, Broadridge Financial, IDEXX

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Broadridge Financial, IDEXX Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
C
I
U
U
F
M
R
T
U
B
J
M

IDEXX gains in relief rally after forecast cut not bad as feared

BUZZ-IDEXX gains in relief rally after forecast cut not bad as feared ** Shares of IDEXX Laboratories IDXX.O gain 4.83% to $477.01 ** Co lowers its annual revenue forecast as the animal health diagnostic equipment maker sees fewer pet owners visiting veterinary clinics ** IDEXX sees 2024 revenue between $3.89 bln and $3.95 bln, lower than previous
I

IDEXX Laboratories Inc reports results for the quarter ended in June - Earnings Summary

IDEXX Laboratories Inc reports results for the quarter ended in June - Earnings Summary IDEXX Laboratories Inc IDXX.OQ reported quarterly adjusted earnings of $3.02​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $2.67. The mean expectation of ten analysts for the quarter was for earnings of $2.88 per share.
I

IDEXX Labs cuts annual forecast as vet visits remain slow

IDEXX Labs cuts annual forecast as vet visits remain slow Aug 6 - IDEXX Laboratories IDXX.O lowered its annual revenue forecast on Tuesday as the animal health diagnostic equipment maker sees fewer pet owners visiting veterinary clinics. WHY IT'S IMPORTANT Inflationary pressures have made pet owners more cautious about visiting the doctor while staffing challenges at veterinary clinics have also weighed down on a recovery in the sector.
I

IDEXX Q2 EPS USD 2.44 Vs. IBES Estimate USD 2.88

BRIEF-IDEXX Q2 EPS USD 2.44 Vs. IBES Estimate USD 2.88 Aug 06 (Reuters) - IDEXX Q2 revenue USD 1,004 million vs. IBES estimate USD 1,006 million. Q2 EBIT margin 26.3% Q2 gross margin 61.7% outlook FY revenue growth 6.2-7.8% outlook FY EPS USD 10.31-10.59
I

What to Watch in the Day Ahead - Tuesday, August 6

What to Watch in the Day Ahead - Tuesday, August 6 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Yum Brands is scheduled to post a marginal fall in same-store sales in the second quarter as demand for fast food in the U.S.
G
I
K
M
U

What to Watch in the Week Ahead and on Monday, August 5

What to Watch in the Week Ahead and on Monday, August 5 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY The Institute for Supply Management's non-manufacturing PMI number is likely to show the sector expanded in July with an expected reading of 51. The index stood at 48.8 in the previ
G
I
M
N
T
R

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Cintas Corp CTAS.OQ +5.9% Warner Bros Discovery Inc WBD.OQ +3.4% Meta Platforms Inc META.OQ +3.2% Broadcom Inc AVGO.OQ +2.5% NVIDIA Corp NVDA.OQ +2.3% Bottom Performers Percent Change MongoDB Inc MDB.OQ -5.2% IDEXX Laboratories Inc IDXX.OQ -5.1% Cadence Design Systems Inc CDNS.OQ -4.2% Walgreens Boots Alliance Inc WBA.OQ -4.0% CrowdStrike Holdings Inc CRWD.OQ -3.6% The Nasdaq 100
B
C
C
I
N
W
U
C

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change DR Horton Inc DHI.N +9.9% Quanta Services Inc PWR.N +6.7% Cintas Corp CTAS.OQ +6.1% Allstate Corp ALL.N +3.2% Warner Bros Discovery Inc WBD.OQ +3.1% Bottom Performers Percent Change Domino's Pizza Inc DPZ.N -13.6% Eli Lilly and Co LLY.
C
I
U
Q



Şartlar

Popüler varlıklar

Bildirim: XM Group şirketlerinin her biri yalnızca gerçekleştirme hizmeti ve online yatırım platformumuza erişim sağlar. Herhangi bir kişinin web sitesinde bulunan veya web sitesi üzerinden sağlanan içeriği görüntülemesine ve/veya kullanmasına izin vermek, bu hizmeti değiştirmek veya genişletmek amaçlı değildir ve bu hizmeti ne değiştirir ne de genişletir. Bu tür erişim ve kullanım her zaman şunlara tabidir: (i) Şartlar ve Koşullar; (ii) Risk Uyarıları ve (iii) Tam Bildirim. Bu nedenle bu tür içerikler yalnızca genel bilgi amacıyla sağlanır. Özellikle, online yatırım platformumuzun içeriklerinin finans piyasalarında herhangi bir işleme girmek için bir teşvik veya bir teklif olmadığını lütfen dikkate alın. Herhangi bir finans piyasasında yatırım yapmak sermayeniz için önemli düzeyde risk taşır.

Online yatırım platformumuzda yayınlanan tüm materyaller yalnızca eğitim/bilgilendirme amaçlıdır ve finansal tavsiye, yatırım vergisi veya yatırım tavsiyesi ve önerileri ya da yatırım fiyatlarımızın kaydı veya herhangi bir finansal enstrümanda işlem yapılması için bir teklif veya teşvik ya da talep edilmemiş finansal promosyonları içermez ve içerdiği şeklinde bir değerlendirme yapılmamalıdır.

Görüşler, haberler, araştırma, analizler, fiyatlar, diğer bilgiler veya bu web sitesinde bulunan üçüncü taraf sitelere verilen bağlantılar gibi her türlü üçüncü taraf içeriğin yanı sıra XM tarafından hazırlanan içerik de “olduğu gibi” esasına göre, genel piyasa yorumu olarak sağlanır ve bir yatırım tavsiyesi oluşturmaz. Herhangi bir içeriğin yatırım araştırması olarak yorumlanmasıyla ilgili olarak, içeriğin bağımsız yatırım araştırmasını desteklemek üzere tasarlanmış yasal gerekliliklere uygun hazırlanmadığını ve bu amacın güdülmediğini, aynı şekilde ilgili yasalar ve mevzuatlar kapsamında pazarlama iletişimi olarak değerlendirileceğini dikkate almalı ve kabul etmelisiniz. Buradan erişebileceğiniz Bağımsız Olmayan Yatırım Araştırması Bildirimimizi ve yukarıdaki bilgilerle ilgili Risk Uyarımızı okuduğunuzdan ve anladığınızdan emin olun.

Risk uyarısı: Sermayeniz risk altında. Kaldıraçlı ürünler herkese uygun olmayabilir. Lütfen Risk Bildirimi'mizi dikkate alın.